Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Type 2 Diabetes Mellitus Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Type 2 Diabetes Mellitus Therapeuticsmarket, defines the market attractiveness level of Type 2 Diabetes Mellitus Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Type 2 Diabetes Mellitus Therapeutics industry, describes the types of Type 2 Diabetes Mellitus Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Type 2 Diabetes Mellitus Therapeutics market and the development prospects and opportunities of Type 2 Diabetes Mellitus Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Type 2 Diabetes Mellitus Therapeutics market in Chapter 13.
By Player:
Takeda Pharmaceutical Company Limited
Novartis
Eli Lilly
Novo Nordisk
Bristol-Myers Squibb
Merck
Disha Pharmaceutical Group
Sanofi
Salix Pharmaceuticals
Boehringer Ingelheim
Ji’Nan Orgachem Pharmaceutical Co Ltd
Henan Tian Fang Pharmaceutical Co Ltd
Shihuida PHARMA Group
AstraZeneca
By Type:
Biguanides
Insulin
Thiazolidinediones
Insulin Secretagogues
Others
By End-User:
Hospital
Clinic
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Type 2 Diabetes Mellitus Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Type 2 Diabetes Mellitus Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Type 2 Diabetes Mellitus Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Type 2 Diabetes Mellitus Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Type 2 Diabetes Mellitus Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Type 2 Diabetes Mellitus Therapeutics Consumption (2017-2022)
-
7.2 United States Type 2 Diabetes Mellitus Therapeutics Consumption (2017-2022)
-
7.3 Europe Type 2 Diabetes Mellitus Therapeutics Consumption (2017-2022)
-
7.4 China Type 2 Diabetes Mellitus Therapeutics Consumption (2017-2022)
-
7.5 Japan Type 2 Diabetes Mellitus Therapeutics Consumption (2017-2022)
-
7.6 India Type 2 Diabetes Mellitus Therapeutics Consumption (2017-2022)
-
7.7 South Korea Type 2 Diabetes Mellitus Therapeutics Consumption (2017-2022)
8 Region and Country-wise Type 2 Diabetes Mellitus Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Type 2 Diabetes Mellitus Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Type 2 Diabetes Mellitus Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Type 2 Diabetes Mellitus Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Type 2 Diabetes Mellitus Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Type 2 Diabetes Mellitus Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Type 2 Diabetes Mellitus Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Type 2 Diabetes Mellitus Therapeutics Consumption Forecast (2022-2028)
9 Global Type 2 Diabetes Mellitus Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Type 2 Diabetes Mellitus Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Biguanides Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Insulin Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Thiazolidinediones Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Insulin Secretagogues Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Type 2 Diabetes Mellitus Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Type 2 Diabetes Mellitus Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Type 2 Diabetes Mellitus Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Biguanides Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Insulin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Thiazolidinediones Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Insulin Secretagogues Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Type 2 Diabetes Mellitus Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Type 2 Diabetes Mellitus Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Type 2 Diabetes Mellitus Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Type 2 Diabetes Mellitus Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Type 2 Diabetes Mellitus Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Type 2 Diabetes Mellitus Therapeutics Market Competitive Analysis
-
14.1 Takeda Pharmaceutical Company Limited
-
14.1.1 Takeda Pharmaceutical Company Limited Company Details
-
14.1.2 Takeda Pharmaceutical Company Limited Type 2 Diabetes Mellitus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Takeda Pharmaceutical Company Limited Type 2 Diabetes Mellitus Therapeutics Product and Service
-
14.2 Novartis
-
14.2.1 Novartis Company Details
-
14.2.2 Novartis Type 2 Diabetes Mellitus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novartis Type 2 Diabetes Mellitus Therapeutics Product and Service
-
14.3 Eli Lilly
-
14.3.1 Eli Lilly Company Details
-
14.3.2 Eli Lilly Type 2 Diabetes Mellitus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Eli Lilly Type 2 Diabetes Mellitus Therapeutics Product and Service
-
14.4 Novo Nordisk
-
14.4.1 Novo Nordisk Company Details
-
14.4.2 Novo Nordisk Type 2 Diabetes Mellitus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novo Nordisk Type 2 Diabetes Mellitus Therapeutics Product and Service
-
14.5 Bristol-Myers Squibb
-
14.5.1 Bristol-Myers Squibb Company Details
-
14.5.2 Bristol-Myers Squibb Type 2 Diabetes Mellitus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bristol-Myers Squibb Type 2 Diabetes Mellitus Therapeutics Product and Service
-
14.6 Merck
-
14.6.1 Merck Company Details
-
14.6.2 Merck Type 2 Diabetes Mellitus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Merck Type 2 Diabetes Mellitus Therapeutics Product and Service
-
14.7 Disha Pharmaceutical Group
-
14.7.1 Disha Pharmaceutical Group Company Details
-
14.7.2 Disha Pharmaceutical Group Type 2 Diabetes Mellitus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Disha Pharmaceutical Group Type 2 Diabetes Mellitus Therapeutics Product and Service
-
14.8 Sanofi
-
14.8.1 Sanofi Company Details
-
14.8.2 Sanofi Type 2 Diabetes Mellitus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Sanofi Type 2 Diabetes Mellitus Therapeutics Product and Service
-
14.9 Salix Pharmaceuticals
-
14.9.1 Salix Pharmaceuticals Company Details
-
14.9.2 Salix Pharmaceuticals Type 2 Diabetes Mellitus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Salix Pharmaceuticals Type 2 Diabetes Mellitus Therapeutics Product and Service
-
14.10 Boehringer Ingelheim
-
14.10.1 Boehringer Ingelheim Company Details
-
14.10.2 Boehringer Ingelheim Type 2 Diabetes Mellitus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Boehringer Ingelheim Type 2 Diabetes Mellitus Therapeutics Product and Service
-
14.11 Ji’Nan Orgachem Pharmaceutical Co Ltd
-
14.11.1 Ji’Nan Orgachem Pharmaceutical Co Ltd Company Details
-
14.11.2 Ji’Nan Orgachem Pharmaceutical Co Ltd Type 2 Diabetes Mellitus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Ji’Nan Orgachem Pharmaceutical Co Ltd Type 2 Diabetes Mellitus Therapeutics Product and Service
-
14.12 Henan Tian Fang Pharmaceutical Co Ltd
-
14.12.1 Henan Tian Fang Pharmaceutical Co Ltd Company Details
-
14.12.2 Henan Tian Fang Pharmaceutical Co Ltd Type 2 Diabetes Mellitus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Henan Tian Fang Pharmaceutical Co Ltd Type 2 Diabetes Mellitus Therapeutics Product and Service
-
14.13 Shihuida PHARMA Group
-
14.13.1 Shihuida PHARMA Group Company Details
-
14.13.2 Shihuida PHARMA Group Type 2 Diabetes Mellitus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Shihuida PHARMA Group Type 2 Diabetes Mellitus Therapeutics Product and Service
-
14.14 AstraZeneca
-
14.14.1 AstraZeneca Company Details
-
14.14.2 AstraZeneca Type 2 Diabetes Mellitus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 AstraZeneca Type 2 Diabetes Mellitus Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Type 2 Diabetes Mellitus Therapeutics
-
Figure Type 2 Diabetes Mellitus Therapeutics Picture
-
Table Global Type 2 Diabetes Mellitus Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Type 2 Diabetes Mellitus Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Type 2 Diabetes Mellitus Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Type 2 Diabetes Mellitus Therapeutics Consumption by Country (2017-2022)
-
Figure United States Type 2 Diabetes Mellitus Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Type 2 Diabetes Mellitus Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Type 2 Diabetes Mellitus Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Type 2 Diabetes Mellitus Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Type 2 Diabetes Mellitus Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Type 2 Diabetes Mellitus Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Type 2 Diabetes Mellitus Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Type 2 Diabetes Mellitus Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Type 2 Diabetes Mellitus Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Type 2 Diabetes Mellitus Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Type 2 Diabetes Mellitus Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Type 2 Diabetes Mellitus Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Type 2 Diabetes Mellitus Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biguanides Consumption and Growth Rate (2017-2022)
-
Figure Global Insulin Consumption and Growth Rate (2017-2022)
-
Figure Global Thiazolidinediones Consumption and Growth Rate (2017-2022)
-
Figure Global Insulin Secretagogues Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Biguanides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Thiazolidinediones Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Insulin Secretagogues Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Type 2 Diabetes Mellitus Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Type 2 Diabetes Mellitus Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Takeda Pharmaceutical Company Limited (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Company Limited Type 2 Diabetes Mellitus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Company Limited Type 2 Diabetes Mellitus Therapeutics Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Type 2 Diabetes Mellitus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Type 2 Diabetes Mellitus Therapeutics Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Type 2 Diabetes Mellitus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Type 2 Diabetes Mellitus Therapeutics Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Type 2 Diabetes Mellitus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Type 2 Diabetes Mellitus Therapeutics Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Type 2 Diabetes Mellitus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Type 2 Diabetes Mellitus Therapeutics Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Type 2 Diabetes Mellitus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Type 2 Diabetes Mellitus Therapeutics Product and Service
-
Table Disha Pharmaceutical Group (Foundation Year, Company Profile and etc.)
-
Table Disha Pharmaceutical Group Type 2 Diabetes Mellitus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Disha Pharmaceutical Group Type 2 Diabetes Mellitus Therapeutics Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Type 2 Diabetes Mellitus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Type 2 Diabetes Mellitus Therapeutics Product and Service
-
Table Salix Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Salix Pharmaceuticals Type 2 Diabetes Mellitus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Salix Pharmaceuticals Type 2 Diabetes Mellitus Therapeutics Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Type 2 Diabetes Mellitus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Type 2 Diabetes Mellitus Therapeutics Product and Service
-
Table Ji’Nan Orgachem Pharmaceutical Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Ji’Nan Orgachem Pharmaceutical Co Ltd Type 2 Diabetes Mellitus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ji’Nan Orgachem Pharmaceutical Co Ltd Type 2 Diabetes Mellitus Therapeutics Product and Service
-
Table Henan Tian Fang Pharmaceutical Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Henan Tian Fang Pharmaceutical Co Ltd Type 2 Diabetes Mellitus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Henan Tian Fang Pharmaceutical Co Ltd Type 2 Diabetes Mellitus Therapeutics Product and Service
-
Table Shihuida PHARMA Group (Foundation Year, Company Profile and etc.)
-
Table Shihuida PHARMA Group Type 2 Diabetes Mellitus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shihuida PHARMA Group Type 2 Diabetes Mellitus Therapeutics Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Type 2 Diabetes Mellitus Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Type 2 Diabetes Mellitus Therapeutics Product and Service
-
